(Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | -8.03%5.86B | -8.92%3.76B | 7.06%2.04B | -0.82%9.3B | -4.14%6.37B | 0.75%4.12B | 7.38%1.9B | -13.93%9.37B | 0.10%6.65B | -2.96%4.09B |
Operating income | -8.03%5.86B | -8.92%3.76B | 7.06%2.04B | -0.82%9.3B | -4.14%6.37B | 0.75%4.12B | 7.38%1.9B | -13.93%9.37B | 0.10%6.65B | -2.96%4.09B |
Operating expenses | 5.67%-3.57B | 6.65%-2.32B | -14.26%-1.31B | 6.36%-5.95B | 7.43%-3.79B | 0.82%-2.48B | -3.11%-1.15B | 10.58%-6.35B | -5.28%-4.09B | -4.69%-2.5B |
Gross profit | -11.48%2.29B | -12.35%1.44B | -3.94%723.98M | 10.83%3.35B | 1.14%2.58B | 3.22%1.64B | 14.63%753.67M | -20.22%3.02B | -7.20%2.56B | -12.96%1.59B |
Selling expenses | 36.21%-9.3M | 43.39%-6.69M | 45.94%-3.9M | 44.38%-19.79M | 43.64%-14.58M | 31.87%-11.83M | 46.04%-7.21M | 40.41%-35.58M | 42.12%-25.86M | 42.00%-17.36M |
Administrative expenses | 3.18%-277.76M | 6.54%-170.72M | 5.46%-89.1M | -8.89%-483.18M | 7.38%-286.9M | 5.49%-182.67M | -7.10%-94.25M | 22.41%-443.72M | -19.16%-309.77M | -13.51%-193.28M |
Research and development expenses | -16.29%-23.03M | 0.80%-13.8M | -2.54%-6.23M | 27.97%-33.48M | 25.93%-19.8M | 23.84%-13.91M | 34.06%-6.08M | 23.27%-46.48M | -4.70%-26.73M | 8.11%-18.26M |
Profit from asset sales | -96.05%503.42K | -100.75%-95.13K | 316.77%26.96K | 87.11%13.65M | 163.40%12.75M | 163.89%12.75M | -103.85%-12.44K | -58.04%7.3M | -67.97%4.84M | -68.27%4.83M |
Revaluation surplus | -76.61%37.99M | -119.79%-29.34M | -11,580.55%-63.01M | 61.39%153.61M | 214.61%162.43M | 33.99%148.23M | 176.74%548.87K | -72.67%95.18M | -26.69%51.63M | 300.71%110.63M |
-Changes in the fair value of other assets | -76.61%37.99M | -119.79%-29.34M | -11,580.55%-63.01M | 61.39%153.61M | 214.61%162.43M | 33.99%148.23M | 176.74%548.87K | -72.67%95.18M | -26.69%51.63M | 300.71%110.63M |
Impairment and provision | -152.60%-135.09M | -134.40%-133.12M | -212.74%-2.76M | 6.03%-232.43M | -100.07%-53.48M | -137.22%-56.79M | -262.17%-883.1K | -46.11%-247.34M | -881.11%-26.73M | -598.83%-23.94M |
-Other impairment is provision | -152.60%-135.09M | -134.40%-133.12M | -212.74%-2.76M | 6.03%-232.43M | -100.07%-53.48M | -137.22%-56.79M | -262.17%-883.1K | -46.11%-247.34M | -881.11%-26.73M | -598.83%-23.94M |
Special items of operating profit | 20.80%808.07M | 55.51%586.84M | 73.33%371.46M | -0.97%1.55B | -53.97%668.96M | 8.03%377.37M | -1.62%214.31M | 55.00%1.57B | 86.50%1.45B | -40.04%349.33M |
Operating profit | -12.36%2.65B | -12.89%1.65B | 7.89%919.47M | 9.81%4.25B | -17.11%3.02B | 6.33%1.9B | 12.66%852.2M | -8.22%3.87B | 12.71%3.65B | -15.45%1.79B |
Financing cost | 20.78%-756.85M | 15.87%-559.05M | -9.51%-284.66M | 10.56%-1.24B | 14.91%-955.34M | 7.47%-664.49M | -13.37%-259.93M | -52.53%-1.39B | -55.30%-1.12B | -64.02%-718.16M |
Special items of earning before tax | 105.25%4.23M | 115.10%4.97M | 291.74%2.89M | -3,726.65%-97.78M | -1,182.97%-80.72M | -882.06%-32.89M | -160.14%-1.51M | -105.58%-2.56M | -43.77%7.45M | -61.94%4.21M |
Earning before tax | -4.54%1.9B | -8.44%1.1B | 7.94%637.7M | 17.35%2.92B | -21.51%1.99B | 12.09%1.2B | 11.54%590.76M | -25.99%2.48B | 0.23%2.53B | -36.40%1.07B |
Tax | 7.54%-395.93M | 8.03%-248.55M | -2.27%-125.03M | -0.09%-529.8M | 7.58%-428.22M | -41.15%-270.25M | -34.67%-122.26M | 3.96%-529.32M | -9.44%-463.36M | 47.43%-191.46M |
After-tax profit from continuing operations | -3.72%1.5B | -8.56%851.18M | 9.43%512.67M | 22.02%2.39B | -24.63%1.56B | 5.77%930.82M | 6.76%468.51M | -30.32%1.96B | -1.63%2.07B | -33.36%880.03M |
Earning after tax | -3.72%1.5B | -8.56%851.18M | 9.43%512.67M | 22.02%2.39B | -24.63%1.56B | 5.77%930.82M | 6.76%468.51M | -30.32%1.96B | -1.63%2.07B | -33.36%880.03M |
Minority profit | 543.38%126.63M | 4,893.93%77.32M | 60.71%41.71M | 195.66%58.63M | -60.47%19.68M | -95.06%1.55M | 0.79%25.95M | -131.79%-61.29M | -71.87%49.79M | -72.03%31.32M |
Profit attributable to shareholders | -10.71%1.37B | -16.72%773.86M | 6.42%470.96M | 15.41%2.33B | -23.75%1.54B | 9.49%929.28M | 7.13%442.55M | -22.83%2.02B | 4.83%2.02B | -29.78%848.71M |
Basic earnings per share | -11.84%0.566 | -18.75%0.312 | 7.14%0.195 | 17.04%0.982 | -25.44%0.642 | 10.66%0.384 | 8.33%0.182 | -24.62%0.839 | 5.13%0.861 | -32.23%0.347 |
Diluted earnings per share | -11.84%0.566 | -18.75%0.312 | 7.14%0.195 | 17.04%0.982 | -25.44%0.642 | 10.66%0.384 | 8.33%0.182 | -24.62%0.839 | 5.13%0.861 | -32.23%0.347 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Huayong Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data